Abridge AI, Inc.

Based in the US, Abridge AI, Inc. specializes in generative AI technology that transforms clinical conversations into actionable, billable notes, enhancing the efficiency of healthcare providers and improving patient outcomes. Founded in 2018, Abridge AI, Inc. operates from its headquarters in Pittsburgh, US, focusing on innovative healthcare documentation solutions.

The founders Shivdev Rao, Julien Hautier, and Sandeep Konam have collectively contributed to the company's growth. Abridge has successfully secured a total of USD 315. 935 mn in funding from various rounds, with the latest being a Series E round led by Andreessen Horowitz and Khosla Ventures, completed on June 12, 2025. The company has engaged in 8 major funding deals, reflecting its robust positioning within the healthcare technology sector.

Abridge specializes in advanced generative AI technology tailored for clinical conversations, transforming patient-clinician interactions into contextually aware, clinically useful, and billable AI-generated notes. The Abridge Contextual Reasoning Engine streamlines clinical documentation by capturing conversation essences in real-time, significantly reducing clinicians’ cognitive load and enhancing patient care. Their solutions serve a diverse clientele, including healthcare leaders such as Johns Hopkins, Kaiser Permanente, Duke Health, and the Mayo Clinic, improving clinician efficiency and patient outcomes across various settings. Abridge's products integrate seamlessly into existing workflows and support multilingual environments within the United States market, allowing healthcare professionals to focus more on patient care instead of administrative tasks.

Abridge generates revenue through enterprise-grade AI solutions structured as subscription-based models, enabling healthcare organizations to access its innovative clinical documentation technology. Major healthcare providers partner with Abridge to utilize its services, aimed at increasing documentation compliance and closing revenue cycle gaps. The pricing model reflects service value with tailored plans for different healthcare systems. Abridge's flagship offerings enhance operational performance and facilitate accurate capture of billable services in real-time, fostering a collaborative environment with healthcare organizations.

In June 2025, Abridge AI, Inc. raised USD 315. 93 mn in Series E funding, primarily for the development of its healthcare delivery, documentation, and reimbursement processes. The company is strategically focused on launching new products aimed at enhancing the efficiency of clinical documentation and expanding into additional geographic markets.

Specific regions targeted for expansion include urban healthcare systems across the United States, with plans to penetrate new markets by 2026. The recent funding provides Abridge with the necessary resources to support these initiatives and further solidify its position in the healthcare industry.